Cefmenoxime

Revision as of 18:05, 8 April 2015 by Turky Alkathery (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cefmenoxime
Clinical data
Routes of
administration
Intramuscular, intravenous
ATC code
Pharmacokinetic data
Bioavailability100% (given IM)
Protein binding50% to 70%
MetabolismNegligible
Elimination half-life1 hour
ExcretionRenal, unchanged
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H17N9O5S3
Molar mass511.562 g/mol

WikiDoc Resources for Cefmenoxime

Articles

Most recent articles on Cefmenoxime

Most cited articles on Cefmenoxime

Review articles on Cefmenoxime

Articles on Cefmenoxime in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cefmenoxime

Images of Cefmenoxime

Photos of Cefmenoxime

Podcasts & MP3s on Cefmenoxime

Videos on Cefmenoxime

Evidence Based Medicine

Cochrane Collaboration on Cefmenoxime

Bandolier on Cefmenoxime

TRIP on Cefmenoxime

Clinical Trials

Ongoing Trials on Cefmenoxime at Clinical Trials.gov

Trial results on Cefmenoxime

Clinical Trials on Cefmenoxime at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cefmenoxime

NICE Guidance on Cefmenoxime

NHS PRODIGY Guidance

FDA on Cefmenoxime

CDC on Cefmenoxime

Books

Books on Cefmenoxime

News

Cefmenoxime in the news

Be alerted to news on Cefmenoxime

News trends on Cefmenoxime

Commentary

Blogs on Cefmenoxime

Definitions

Definitions of Cefmenoxime

Patient Resources / Community

Patient resources on Cefmenoxime

Discussion groups on Cefmenoxime

Patient Handouts on Cefmenoxime

Directions to Hospitals Treating Cefmenoxime

Risk calculators and risk factors for Cefmenoxime

Healthcare Provider Resources

Symptoms of Cefmenoxime

Causes & Risk Factors for Cefmenoxime

Diagnostic studies for Cefmenoxime

Treatment of Cefmenoxime

Continuing Medical Education (CME)

CME Programs on Cefmenoxime

International

Cefmenoxime en Espanol

Cefmenoxime en Francais

Business

Cefmenoxime in the Marketplace

Patents on Cefmenoxime

Experimental / Informatics

List of terms related to Cefmenoxime

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefmenoxime is a third-generation cephalosporin antibiotic.


External links

  • Template:DiseasesDB
  • Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T (1995). "Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis". Jpn J Antibiot. 48 (5): 602–9. PMID 7637194.
  • Paladino J, Fell R (1994). "Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia". Ann Pharmacother. 28 (3): 384–9. PMID 8193431.
  • Duncker G, Reich U, Krausse R (1994). "Cefmenoxime in corneal organ culture". Ophthalmologica. 208 (5): 262–6. PMID 7816419.


Template:WS